No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
219 |
4. Check minimum number of eventsNone |
219 |
5. Include endpointsNone |
219 |
6. Filter based on genotype QC (FinnGen only) |
211 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Wilms' tumor, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of kidney, except renal pelvis, including Hilmo
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 211 | 76 | 135 |
| Unadjusted period prevalence (%) | 0.05 | 0.03 | 0.06 |
| Median age at first event (years) | 63.16 | 58.93 | 65.55 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 219
- Matched controls
- 2190
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C64.80
ICD-10 Finland
Wilms tumour
+∞
313.8
218
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
219.4
172
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
129.4
111
*
130
Kela drug reimbursment
Malignant tumour
+∞
120.2
104
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
99.8
88
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
1397.3
95.4
86
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
165.4
82.9
83
8
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
47.7
44
*
180
Kela drug reimbursment
Interferon alfa
+∞
39.8
37
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.2
36.1
66
124
JN4BD
NOMESCO Finland
Extensive body CT
10.7
35.8
43
49
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.6
35.0
72
152
8960/3-C64.9
ICD-O-3
Nephroblastoma, NOS, of kidney, NOS
+∞
33.2
31
*
197
Kela drug reimbursment
Sunitinib
+∞
31.0
29
*
H02AB02
ATC
dexamethasone; systemic
57.1
29.4
34
7
L01XE04
ATC
[U] sunitinib
+∞
28.8
27
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
28.8
27
*
KAC00
NOMESCO Finland
Nephrectomy
306.6
27.4
27
*
JN4AD
NOMESCO Finland
Body CT examination
8.5
26.3
37
51
N02AA05
ATC
oxycodone; systemic
5.1
25.7
69
181
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
280.7
25.2
25
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.6
24.8
39
61
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
24.9
24.3
34
16
Z51.5
ICD-10 Finland
Palliative care
10.6
24.0
28
30
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
22.3
21
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
22.3
21
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
21.2
20
*
GD1AD
NOMESCO Finland
Thorax CT examination
8.1
20.9
30
42
N18.8
ICD-10 Finland
Other chronic renal failure
9.3
19.7
25
30
A04AA01
ATC
ondansetron; systemic, rectal
18.1
19.5
30
19
A04AA02
ATC
granisetron; systemic, transdermal
+∞
19.0
18
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
18.9
81
294
7125
FHL
Nephrectomy (extrrafascial)
207.0
18.8
19
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.4
17.9
54
152
WX302
NOMESCO Finland
Thoracal epidural anesthesy
15.7
17.9
29
21
159
Kela drug reimbursment
Pazopanib
+∞
16.9
16
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
183.4
16.7
17
*
116
Kela drug reimbursment
Prostate cancer
+∞
15.8
15
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
25.6
15.4
21
9
WW500
NOMESCO Finland
Blood transfusion
12.7
15.3
27
24
A41.9
ICD-10 Finland
Sepsis, unspecified
6.4
14.8
26
45
KAD00
NOMESCO Finland
Partial nephrectomy
86.0
14.8
16
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
14.7
14
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
29.5
14.5
19
7
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.7
13.8
35
85
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
13.7
13
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
148.8
13.6
14
*
B01AB10
ATC
tinzaparin; parenteral
5.1
13.3
30
66
TK800
NOMESCO Finland
Hemodialysis
14.4
12.7
21
16
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
+∞
12.6
12
*
N02AX02
ATC
tramadol; systemic, rectal
2.7
11.9
110
593
R50.9
ICD-10 Finland
Fever, unspecified
3.3
11.7
54
199
158
Kela drug reimbursment
Everolimus
+∞
11.6
11
*
168
Kela drug reimbursment
Axitinib
+∞
11.6
11
*
1890A
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]
+∞
11.6
11
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
10.5
11.6
22
23
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
45.8
11.0
13
*
UKC02
NOMESCO Finland
Cystoscopy
3.2
10.9
51
189
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
10.7
52
197
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.9
10.5
34
99
L03AA04, ,
ATC
115.3
10.5
11
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.5
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.5
10
*
L01XE11
ATC
[U] pazopanib
+∞
10.5
10
*
322
Kela drug reimbursment
Sunitinib
+∞
10.5
10
*
JN4CD
NOMESCO Finland
Very extensive body CT
20.0
10.4
15
8
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
42.1
10.1
12
*
A06AD11
ATC
lactulose; oral
2.9
10.0
55
224
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.7
9.8
19
36
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
9.8
90
474
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
9.7
57
240
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
9.6
40
138
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
13.2
9.5
16
13
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
5.1
9.5
21
45
1890X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,EI HIST VAHV]
+∞
9.4
9
*
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
+∞
9.4
9
*
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
9.4
9
*
C648, ,
ICD-10 Finland
+∞
9.4
9
*
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
+∞
9.4
9
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
9.4
9
*
U75
ICPC
Malignant neoplasm of kidney
+∞
9.4
9
*
ZXD05
NOMESCO Finland
Urgent procedure
2.5
9.4
80
405
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
38.4
9.1
11
*
R31
ICD-10 Finland
Unspecified haematuria
3.3
9.1
38
131
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.4
8.9
16
15
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
14.8
8.8
14
10
V03AE01
ATC
polystyrene sulfonate; oral
14.8
8.8
14
10
WF002
NOMESCO Finland
Radical radiotherapy
52.1
8.7
10
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
28.8
8.6
11
*
A12AA04
ATC
calcium carbonate; oral
13.5
8.5
14
11
WZC00
NOMESCO Finland
Treatment plan or consultation
2.5
8.5
68
333
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
8.4
8
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
8.4
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.4
8
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
8.4
8
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
8.4
8
*
L02BB03
ATC
bicalutamide; oral
+∞
8.4
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
8.4
8
*
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
+∞
8.4
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
L01XE10
ATC
[U] everolimus
+∞
8.4
8
*
L03AB04
ATC
interferon alfa-2a; parenteral
+∞
8.4
8
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.7
8.3
20
46
XX3DW
NOMESCO Finland
Time consuming IT work
5.1
8.3
18
38
KA1AE
NOMESCO Finland
Kidney ultrasound examination
9.5
8.2
16
18
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
13.7
8.0
13
10
B02AA02
ATC
tranexamic acid; systemic
3.5
7.9
29
92
N02AA01
ATC
morphine; systemic, rectal
15.8
7.8
12
8
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.2
7.8
18
27
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.5
7.7
16
20
ZX120
NOMESCO Finland
Intravenous
3.6
7.5
26
79
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
82.8
7.5
8
*
L02AB02
ATC
medroxyprogesterone; systemic
82.8
7.5
8
*
L03AA02
ATC
filgrastim; parenteral
82.8
7.5
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
7.4
107
666
WZC30
NOMESCO Finland
Teaching
3.1
7.4
34
124
B01AB05
ATC
enoxaparin; parenteral
2.3
7.3
69
360
NK6AN
NOMESCO Finland
Total body bone isotope imaging
+∞
7.3
7
*
L01XE17
ATC
[U] axitinib
+∞
7.3
7
*
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
7.3
7
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
7.3
7
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
7.3
7
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.1
7.2
20
52
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
7.1
90
531
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
7.1
24
72
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
7.1
35
133
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.5
6.9
25
78
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
11.5
6.9
12
11
B03XA02
ATC
darbepoetin alfa; parenteral
11.5
6.9
12
11
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
17.4
6.8
10
6
A11CC03
ATC
alfacalcidol; systemic
6.8
6.8
16
25
M05BX04
ATC
denosumab; parenteral
4.4
6.7
17
41
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
12.8
6.7
11
9
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
12.8
6.7
11
9
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.5
6.6
12
12
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.6
6.5
22
66
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
71.9
6.5
7
*
ZX121
NOMESCO Finland
Central venous catheter
71.9
6.5
7
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
14.9
6.5
10
7
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
6.3
6
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
6.3
6
*
3012
Kela drug reimbursment
Cabozantinib
+∞
6.3
6
*
1502
Kela drug reimbursment
Cabozantinib
+∞
6.3
6
*
343
Kela drug reimbursment
Pazopanib
+∞
6.3
6
*
L01XE26
ATC
[U] cabozantinib
+∞
6.3
6
*
361
Kela drug reimbursment
Axitinib
+∞
6.3
6
*
M05BA02
ATC
clodronic acid; systemic
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.5
6.2
22
68
137
Kela drug reimbursment
Uraemia requiring dialysis
13.0
6.1
10
8
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
6.0
52
259
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
63
241
3.27
13.00
12.1
6.0
1.19
1.11
mmol/l
1.13
63
218
29
73
4.43
10.88
1.6
1.4
3.23
2.65
ug/l
0.35
24
55
103
636
2.17
7.24
8.4
4.4
34.22
35.21
g/l
1.21
98
587
47
211
2.56
6.89
9.9
4.1
0.29
1.72
mmol/l
2.14
36
162
94
570
2.14
6.83
5.7
3.6
—
—
—
0
0
65
340
2.30
6.81
3.8
1.9
—
—
—
0
0
12
12
10.50
6.62
6.0
1.4
29.23
12.94
ug/l
1.11
12
12
46
210
2.51
6.50
10.1
4.1
5.55
5.70
kpa
0.51
46
202
29
105
3.03
6.35
1.4
1.7
—
—
—
0
0
15
24
6.63
6.28
3.1
1.8
26.46
12.51
iu/l
—
9
19
99
637
2.01
5.93
3.8
2.2
—
—
—
0
0
13
25
5.46
4.85
1.3
1.3
—
—
—
0
0
13
25
5.46
4.85
1.3
1.3
—
—
—
0
0
43
217
2.22
4.78
6.0
2.6
22.49
22.75
%
0.05
38
195
15
35
4.52
4.73
1.3
1.3
—
—
—
0
0
115
847
1.75
4.04
18.7
5.7
3.99
4.41
e9/l
1.12
107
725
9
14
6.65
4.02
7.4
6.1
10.73
11.02
mg/l
—
9
14
17
59
3.04
4.00
2.2
1.8
3.05
2.74
ug/l
0.06
17
48
48
271
1.99
3.96
2.2
1.7
—
—
—
0
0
149
1737
0.56
3.79
51.1
19.0
37.24
39.70
%
3.23
130
1602
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
50
3.15
3.77
2.9
2.7
0.30
0.33
u/ml
—
7
30
35
180
2.12
3.70
10.0
3.9
5.54
4.76
kpa
0.80
35
171
9
16
5.81
3.70
1.3
1.3
—
—
—
0
0
9
16
5.81
3.70
1.3
1.3
—
—
—
0
0
36
189
2.08
3.61
1.8
1.8
—
—
—
0
0
15
52
3.02
3.54
1.1
1.5
—
—
—
0
0
36
191
2.06
3.51
1.8
1.7
—
—
—
0
0
11
28
4.08
3.34
1.4
1.2
—
—
—
0
0
119
1452
0.60
3.28
3.9
4.6
5.86
6.08
mmol/l
0.94
111
1291
46
273
1.87
3.25
2.3
1.9
29.33
29.31
s
0.01
46
263
8
15
5.49
3.22
6.6
1.3
11.31
250.68
u/ml
—
8
15
12
35
3.57
3.16
1.3
1.4
—
—
—
0
0
32
170
2.03
3.11
6.3
6.4
2.00
1.66
mmol/l
0.21
22
117
8
16
5.15
3.08
1.5
1.3
—
—
—
0
0
33
180
1.98
2.98
6.6
6.2
5.30
5.03
kpa
0.85
33
175
6
10
6.13
2.71
6.7
3.4
—
—
—
0
0
7
16
4.48
2.49
1.1
1.2
—
—
—
0
0
7
16
4.48
2.49
1.1
1.2
—
—
—
0
0
7
16
4.48
2.49
1.1
1.2
—
—
—
0
0
8
21
3.91
2.49
1.5
1.2
—
—
—
0
0
136
1130
1.54
2.42
15.5
4.9
95.13
84.27
u/l
1.17
131
1031
111
1332
0.66
2.35
29.2
12.5
63.25
75.73
ml/min/173m2
4.04
100
1058
7
18
3.98
2.27
1.1
1.4
—
—
—
0
0
21
108
2.04
2.24
4.8
2.3
53.40
59.46
ml/min/173m2
—
10
41
98
770
1.49
2.22
17.6
17.2
1.36
1.40
inr
0.17
31
203
23
123
1.97
2.21
4.7
1.8
65.07
66.74
g/l
0.41
23
106
6
14
4.37
2.16
1.3
1.3
—
—
—
0
0
50
344
1.59
2.06
5.2
4.0
158.86
352.67
ng/l
0.67
44
283
10
38
2.71
2.03
2.1
2.9
98.00
88.18
%
—
10
38
16
78
2.13
1.96
7.6
2.2
0.53
0.56
%
0.13
16
78
7
22
3.25
1.89
1.0
1.3
—
—
—
0
0
115
956
1.43
1.84
6.9
4.4
6.93
6.79
mmol/l
0.24
110
887
124
1427
0.70
1.84
4.5
4.6
4.45
4.38
mmol/l
0.30
119
1304
6
18
3.40
1.76
1.0
1.4
—
—
—
0
0
118
1364
0.71
1.74
4.4
4.1
1.40
1.24
mmol/l
1.61
113
1226
121
1391
0.71
1.71
6.3
6.5
42.01
40.99
mmol/mol
0.34
116
1276
122
1400
0.71
1.70
7.3
4.3
2.05
2.00
mu/l
0.12
117
1249
16
83
2.00
1.69
7.6
2.2
1.24
1.10
%
0.38
16
83
10
41
2.51
1.66
1.6
1.3
—
—
—
0
0
10
41
2.51
1.66
1.6
1.3
—
—
—
0
0
30
192
1.65
1.65
4.4
5.3
-0.28
1.42
mmol/l
0.92
21
153
146
1621
0.70
1.63
20.3
8.6
33.77
25.04
u/l
0.51
140
1537
7
27
2.64
1.52
4.0
8.1
—
797.83
—
0
6
9
38
2.43
1.47
2.1
1.3
82.68
56.58
mg/l
—
9
33
9
38
2.43
1.47
2.1
1.3
70.23
37.30
mg/l
—
9
33
6
22
2.77
1.44
2.2
1.5
0.57
0.51
nmol/l
—
6
17
29
191
1.60
1.44
4.5
5.3
4.70
5.09
kpa
1.59
29
183
29
191
1.60
1.44
4.5
5.3
12.39
11.32
kpa
0.27
29
183
25
160
1.63
1.39
3.1
2.0
362.68
357.24
nmol/l
0.06
25
140
13
68
1.97
1.36
5.1
3.1
4.19
4.65
pmol/l
0.72
13
59
8
34
2.40
1.30
1.8
1.2
—
—
—
0
0
148
1616
0.74
1.24
39.3
16.6
4.17
4.01
mmol/l
7.84
142
1560
148
1613
0.75
1.19
38.8
16.5
139.08
139.67
mmol/l
1.98
142
1556
39
287
1.44
1.18
4.1
3.2
1.05
1.00
e6/l
0.04
30
171
10
52
1.97
1.08
1.0
1.2
—
—
—
0
0
28
198
1.47
1.04
10.6
4.7
105.96
104.90
mmol/l
0.60
28
198
45
348
1.37
1.03
6.6
4.0
1.01
1.02
kg/l
2.02
15
59
10
53
1.93
1.03
1.0
1.2
—
—
—
0
0
7
35
2.03
1.01
1.1
1.2
—
—
—
0
0
145
1570
0.77
0.99
33.0
13.5
29.26
25.28
mg/l
0.76
130
1199
0
32
0.00
0.96
0.0
1.5
—
—
—
0
0
28
374
0.71
0.90
2.8
2.7
0.72
0.74
ug/l
0.07
22
263
0
27
0.00
0.78
0.0
1.1
—
34.50
—
0
8
14
205
0.66
0.74
1.5
1.3
34.33
13.72
u/ml
—
7
77
5
25
2.02
0.73
5.0
3.3
53.00
59.28
%
—
5
25
38
304
1.30
0.71
2.1
1.7
1.08
1.28
mg/l
0.43
32
236
5
26
1.94
0.71
1.2
1.2
—
—
—
0
0
12
79
1.55
0.64
1.1
1.4
—
—
—
0
0
11
71
1.58
0.63
2.8
1.5
—
—
—
0
0
5
30
1.68
0.62
1.0
1.2
—
—
—
0
0
5
30
1.68
0.62
2.8
2.1
109.20
106.07
mmol/l
—
5
30
61
697
0.83
0.59
1.9
1.9
95.89
92.21
pmol/l
0.29
37
356
35
285
1.27
0.59
4.3
3.4
0.97
1.95
e6/l
0.94
26
168
20
261
0.74
0.58
1.7
1.7
—
—
—
0
0
47
550
0.81
0.57
4.6
3.7
20.72
24.91
%
1.47
25
264
6
36
1.68
0.57
1.7
1.2
—
—
—
0
0
17
125
1.39
0.55
7.6
7.3
24.79
24.56
mmol/l
0.16
17
120
9
64
1.42
0.52
1.0
1.2
9.76
10.29
g/l
—
9
53
63
556
1.19
0.51
3.6
3.4
3424.07
1858.45
ng/l
1.34
58
473
10
67
1.52
0.50
2.8
1.4
—
—
—
0
0
28
341
0.79
0.49
1.3
1.3
0.71
2.23
u/ml
—
7
80
58
655
0.84
0.49
6.1
4.0
848.35
100.05
ng/l
0.46
52
485
33
392
0.81
0.47
9.9
4.0
0.00
0.00
estimate
—
7
107
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
5
34
1.48
0.40
1.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
10
71
1.43
0.40
1.0
1.2
3.52
3.61
g/l
—
10
60
10
71
1.43
0.40
1.0
1.2
—
—
—
0
0
10
71
1.43
0.40
1.0
1.2
8.46
7.69
g/l
—
10
60
121
1140
1.14
0.39
6.1
4.2
15.57
12.67
mm/h
1.00
115
1026
7
52
1.36
0.31
2.9
3.8
—
—
—
0
0
7
57
1.24
0.29
1.0
1.6
—
132.00
—
0
5
8
62
1.30
0.28
1.0
2.0
—
—
—
0
0
8
67
1.20
0.26
1.0
1.2
3.95
3.00
g/l
—
8
56
5
71
0.70
0.26
1.6
1.5
—
—
—
0
0
9
75
1.21
0.25
1.4
2.2
—
—
—
0
0
61
569
1.10
0.22
7.5
3.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
105.36
—
0
11
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
86
902
0.92
0.20
3.6
3.0
—
—
—
0
0
12
99
1.22
0.20
1.3
1.6
—
—
—
0
0
6
51
1.18
0.19
1.5
2.4
332.50
79.33
ug/min
—
6
34
6
52
1.16
0.19
1.3
1.5
—
—
—
0
0
20
223
0.89
0.15
1.3
1.3
19.80
35.35
iu/ml
—
7
70
12
138
0.86
0.13
1.9
2.2
—
—
—
0
0
11
127
0.86
0.13
1.7
2.0
—
—
—
0
0
53
504
1.07
0.12
4.7
3.8
35.71
10.20
mg/mmol
1.69
42
325
5
44
1.14
0.10
1.0
1.6
—
—
—
0
0
5
44
1.14
0.10
8.0
1.9
123.60
131.09
g/l
—
5
32
10
87
1.16
0.09
1.2
1.1
—
—
—
0
0
6
55
1.09
0.09
1.2
2.1
36.78
39.98
u/l
—
6
46
15
139
1.08
0.05
3.1
3.1
—
—
—
0
0
78
765
1.03
0.05
7.0
3.8
0.00
0.00
estimate
—
8
108
76
751
1.02
0.02
7.0
3.9
0.00
0.00
estimate
—
9
122
19
193
0.98
0.00
17.7
8.0
—
—
—
0
0
11
106
1.04
0.00
2.1
1.5
—
—
—
0
0
75
753
0.99
0.00
9.7
5.3
0.00
0.00
estimate
—
7
109
11
115
0.95
0.00
20.0
3.3
1.23
1.22
mmol/l
0.37
11
96
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.4
—
71.52
—
0
8
0
9
0.00
-0.00
0.0
2.2
—
686.11
—
0
9
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1715.80
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
14
140
1.00
-0.00
1.3
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
55
0.91
-0.00
1.0
1.1
2.20
0.01
g/l
—
5
47
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
0.48
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_WILMS_TUMOR_WIDE – Wilms' tumor, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).